Use of a gestational carrier for a patient with recurrent adverse pregnancy outcomes from early onset severe pre-eclampsia

Fertility and Sterility

Volumn 87, Issue 1, 2007, Pages 189.e1-189.e3

  Farley, Darren M ^a   Grainger, David A ^a,b,c   Tjaden, Bruce L ^a,b,c   Frazier, Linda M ^a,b   Maki, Janey E ^a,d  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b Dept of Obstetrics Gynecology   (United States)

^c Center for Reproductive Medicine   (United States)

^d Miles City Health Care Clinic   (United States)

Author keywords

fertilization in vitro; HELLP syndrome; Pre eclampsia; surrogate mothers

Indexed keywords

ESTRADIOL; GONADOTROPIN; PROGESTERONE;

ADULT; ARTICLE; CASE REPORT; DELIVERY; DISEASE SEVERITY; FEMALE; FETUS DEATH; GESTATION PERIOD; HELLP SYNDROME; HUMAN; NEWBORN DEATH; ONSET AGE; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; SPERM; SUPPLEMENTATION; TERTIARY HEALTH CARE;

EID: 33845782404     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.04.050     Document Type: Article

References (25)

1. ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 99 (2002) 159-167 Number 33, January 2002
2. Sibai B.M., Taslimi M., Abdella T.N., Brooks T.F., Spinnato J.A., and Anderson G.D. Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester. Am J Obstet Gynecol 152 (1985) 32-37
3. Sibai B., Mercer B., and Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Obstet Gynecol 165 (1991) 1408-1412
4. Egerman R.S., and Sibai B.M. HELLP syndrome. Clin Obstet Gynecol 42 (1999) 381-389
5. Baxter J.K., and Weinstein L. HELLP syndrome: the state of the art. Obstet Gynecol Surv 59 (2004) 838-845
6. Sibai B.M., Mercer B.M., Schiff E., and Friedman S.A. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 171 (1994) 818-822
7. Thomas T., Jophy R., Mhaskar A., and Misquith D. Are we increasing serious maternal morbidity by postponing termination of pregnancy in severe pre-eclampsia/eclampsia?. J Obstet Gynaecol 25 (2005) 347-351
8. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 (2005) 1592-1594
9. Saftlas A.F., Beydoun H., and Triche E. Immunogenetic determinants of preeclampsia and related pregnancy disorders: a systematic review. Obstet Gynecol 106 (2005) 162-172
10. Schlembach D., Beinder E., Zingsem J., Wunsiedler U., Beckmann M.W., and Fischer T. Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction. Clin Sci (Lond) 105 (2003) 279-285
11. Benedetto C., Marozio L., Salton L., Maula V., Chieppa G., and Massobrio M. Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome. Acta Obstet Gynecol Scand 81 (2002) 1095-1100
12. Jeschke U., Kunert-Keil C., Mylonas I., Hammer A., Schiessl B., Lomba I., et al. Expression of glycodelin A in decidual tissue of preeclamptic, HELLP and intrauterine growth-restricted pregnancies. Virchows Arch 446 (2005) 360-368
13. Raijmakers M.T., Roes E.M., te Morsche R.H., Steegers E.A., and Peters W.H. Haptoglobin and its association with HELLP syndrome. J Med Genet 40 (2003) 214-216
14. Mello G., Parretti E., Marozio L., Pizzi C., Lojacono A., Frusca T., et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension 46 (2005) 1270-1274
15. Li Thi Thuong D., Tieulie N., Costedoat N., Andreu M.R., Wechsler B., Vauthier-Brouzes D., et al. The HELLP syndrome and the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 64 (2005) 273-278
16. Herrmann W., Hubner U., Koch I., Obeid R., Retzke U., and Geisel J. Alteration of homocysteine catabolism in pre-eclampsia, HELLP syndrome and placental insufficiency. Clin Chem Lab Med 42 (2004) 1109-1116
17. Dekker G. The partner's role in the etiology of preeclampsia. J Reprod Immunol 57 (2002) 203-215
18. Dekker G.A., and Robillard P.Y. Preeclampsia: a couple's disease with maternal and fetal manifestations. Curr Pharm Des 11 (2005) 699-710
19. Wright V., Schieve L.A., Reynolds M.A., and Jeng G. Assisted reproductive technology surveillance-United States, 2002. MMWR Surveill Summ 54 (2005) 1-24
20. Raziel A., Friedler S., Schachter M., Strassburger D., and Ron-El R. Successful pregnancy after 24 consecutive fetal losses: lessons learned from surrogacy. Fertil Steril 74 (2000) 104-106
21. Duley L., Henderson-Smart D.J., Knight M., and King J.F. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev (2004) CD004659
22. Sibai B.M. Prevention of preeclampsia: a big disappointment. Am J Obstet Gynecol 179 (1998) 1275-1278
23. Levine R.J., Hauth J.C., Curet L.B., Sibai B.M., Catalano P.M., Morris C.D., et al. Trial of calcium to prevent preeclampsia. N Engl J Med 337 (1997) 69-76
24. Caritis S., Sibai B., Hauth J., Lindheimer M.D., Klebanoff M., Thom E., et al. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 338 (1998) 701-705
25. Beazley D., Ahokas R., Livingston J., Griggs M., and Sibai B.M. Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. Am J Obstet Gynecol 192 (2005) 520-521